Which has the lower trailing P/E, BTSG or CORT?

BTSG has the lower trailing P/E: BTSG trades at 46.27 and CORT at 290.55. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BTSG or CORT?

Over the past five years, CORT grew revenue faster — BTSG at a 18.92% CAGR versus CORT at 19.35%.

Is BTSG or CORT more profitable?

CORT runs the higher net margin — BTSG at 2.05% versus CORT at 6.61%.

BrightSpring Health Services, Inc. Common Stock (BTSG) vs Corcept Therapeutics Incorporated (CORT)

A side-by-side comparison of BrightSpring Health Services, Inc. Common Stock and Corcept Therapeutics Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BTSG

BrightSpring Health Services, Inc. Common Stock

$12.17B

$62.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

CORT

Corcept Therapeutics Incorporated

$13.19B

$122.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BTSG vs CORT

growth of $100 · dividends reinvested · last 3y

BTSG +463.6% (+78.0%/yr)CORT +463.4% (+77.9%/yr)BTSG compounded faster over this window

BTSG CORT

BTSG vs CORT: by the numbers

•CORT is the larger company ($13.19B vs $12.17B market cap).
•BTSG trades at the lower trailing earnings multiple (46.27 vs 290.55 P/E), one valuation lens rather than an overall verdict.
•CORT converts more revenue to profit (6.61% vs 2.05% net margin).
•CORT grew revenue faster over the past five years (19.35% vs 18.92% CAGR).

Metrics side by side

Valuation

Metric	BTSG	CORT
P/E ratio	46.27	290.55
Forward P/E	34.10	N/A
PEG ratio	0.95	N/A
P/S ratio	0.85	15.88
P/B ratio	5.94	18.69
EV / EBITDA	21.92	1483.24
FCF yield	3.31%	0.81%

Profitability

Metric	BTSG	CORT
Gross margin	12.38%	98.30%
Operating margin	3.33%	0.77%
Net margin	2.05%	6.61%
ROE	14.35%	7.78%
ROIC	8.97%	0.87%

Growth (annualized)

Metric	BTSG	CORT
Revenue CAGR (5Y)	18.92%	19.35%
EPS CAGR (5Y)	50.94%	0.64%
FCF CAGR (5Y)	9.24%	-4.40%
Total return CAGR (5Y)	N/A	43.90%

Frequently asked

Which has the lower trailing P/E, BTSG or CORT?: BTSG has the lower trailing P/E: BTSG trades at 46.27 and CORT at 290.55. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BTSG or CORT?: Over the past five years, CORT grew revenue faster — BTSG at a 18.92% CAGR versus CORT at 19.35%.
Is BTSG or CORT more profitable?: CORT runs the higher net margin — BTSG at 2.05% versus CORT at 6.61%.

Go deeper

Full BTSG analysis Full CORT analysis Interactive comparison tool

Dig into the metrics

BrightSpring Health Services, Inc. Common Stock P/E ratio Corcept Therapeutics P/E ratio BrightSpring Health Services, Inc. Common Stock ROE Corcept Therapeutics ROE BrightSpring Health Services, Inc. Common Stock operating margin Corcept Therapeutics operating margin BrightSpring Health Services, Inc. Common Stock revenue growth Corcept Therapeutics revenue growth BrightSpring Health Services, Inc. Common Stock free cash flow Corcept Therapeutics free cash flow

BrightSpring Health Services, Inc. Common Stock & Corcept Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.